Regulatory Information
DKSH SINGAPORE PTE. LTD.
DKSH SINGAPORE PTE. LTD.
Therapeutic
General Sale List
Formulation Information
POWDER
**HOW SHOULD THIS MEDICINE BE USED?** **Recommended Dosage** **_Children:_** - 2 years: 1 to 2 sachets per day - Over the age of 2 years: 2 to 3 sachets per day _**Adults:**_ An average of 3 sachets per day for 7 days. The contents should be thoroughly stirred in 50 ml of water. In case of acute diarrhoea, the daily dosage can be doubled at the beginning of the treatment. **Method of Administration** _**Children:**_ The contents of the sachet can be added and thoroughly stirred in the feeding bottle with 50 ml of water, to be given during the day, or thoroughly mixed with a semi-liquid food: broth, stewed fruit, mashed vegetables or baby food. _**Adults:**_ Contents of one sachet should be thoroughly stirred in 50 ml of water before taking. **WHEN SHOULD THIS MEDICINE BE TAKEN?** You should take this medicine preferably in between meals. **HOW LONG SHOULD YOU TAKE THIS MEDICINE FOR?** If the symptoms do not improve within 7 days, consult your doctor.
ORAL
Medical Information
**WHAT IS THIS MEDICINE USED FOR?** - Treatment of acute diarrhoea in children of 2 years and above, in addition to oral rehydration. - Treatment of acute diarrhoea in adults. - Symptomatic treatment of chronic functional diarrhoea in adults. Fluid and electrolyte depletion may occur in patients who have diarrhoea. The use of SMECTA® does not preclude the administration of appropriate fluid and electrolyte therapy, should this prove to be necessary. The extent of rehydration and route of administration (orally or intravenously) must be adapted to the severity of the diarrhoea, the age and clinical context of the patient.
**WHAT YOU SHOULD KNOW BEFORE TAKING THIS MEDICINE** Under **Special Warnings:** Owing to the presence of glucose and saccharine, this medicinal product is contraindicated in patients with a fructose intolerance, glucose and galactose malabsorption syndrome or sucrase/somaltase deficiency (rare hereditary diseases).
A07BC05
diosmectite
Manufacturer Information
DKSH SINGAPORE PTE. LTD.
BEAUFOUR IPSEN INDUSTRIE
Active Ingredients
Documents
Patient Information Leaflets
Smecta Sachet 3g PIL.pdf
Approved: November 22, 2019